Guardant Health (GH) Other financing activities (2018 - 2026)

Guardant Health has disclosed Other financing activities across 8 years of filings, most recently posting $102000.0 for Q1 2026.

• Other financing activities for Q1 2026 came in at $102000.0, down 99.16% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.4 million (down 171.96% YoY), and the FY2025 annual result was $3.6 million, up 2450.33% from the prior year.
• Other financing activities came in at $102000.0 for Q1 2026 at Guardant Health, down from $765000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $21.3 million in Q2 2023 to a low of -$15.4 million in Q3 2023.
• The 4-year median for Other financing activities is $102000.0 (2026), against an average of $1.9 million.
• Peak annual rise in Other financing activities reached 9374.19% in 2025, while the deepest fall reached 2681.28% in 2025.
• Guardant Health's Other financing activities stood at $15.2 million in 2023, then tumbled by 99.61% to $59000.0 in 2024, then soared by 1196.61% to $765000.0 in 2025, then slumped by 86.67% to $102000.0 in 2026.
• The last three Other financing activities figures came in at $102000.0 (Q1 2026), $765000.0 (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.